Article

Experimental Models Showed 27-Gauge Needle Posed the Greatest Risk of Vitreous Contamination

Author(s):

Even when a 32-gauge needle was used, intravitreal injection posed a risk of introducing contamination directly into the eye. However, of all the needle gauges studied, the 27-gauge needle posed the greatest risk.

27-gauge needle, 30-gauge needle, 32-gauge needle, conjunctiva, fluoresbrite carboxylate microspheres, fluorescence strength, fluorophotometry, enucleated porcine eyes, experimental model, intraocular fiber catheter, intravitreous injections, measurement, monitoring, ophthalmology, quantification, risk, saline solution, sclera, vitreous contamination

Japanese researchers used two experimental models of vitreous contamination in enucleated porcine eyes to detect and measure the introduction of such contamination into the eye after intravitreal injection. They published the results of their study in the October, 2016, issue of Retina.

In one experimental model, the researchers applied fluoresbrite carboxylate microspheres to the surface of the conjunctiva to detect the introduction of contamination into the eye during intravitreal injection. They then injected a solution of saline, 0.05 mL, into the eye by using a 27-gauge (G), 30-G, or 32-G needle. They used an intraocular fiber catheter to monitor the injections.

In another experimental model, the researchers applied condensed microspheres to an excised sheet of porcine sclera, then injected a solution of saline, 0.05 mL, from the top of an applied microsphere through the sclera and collected a sample. They used fluorophotometry to measure the fluorescence strength of the samples.

The researchers detected fluorescent microspheres in all 10 eyes injected with 27-G needles. In contrast, they detected these microspheres in 9 of 10 eyes injected with 30-G or 32-G needles. Furthermore, they found significantly greater fluorescence strength in the 27-G needle group than in the 30-G or 32-G needle groups (P < 0.01 for both comparisons).

In addition, they found significantly greater quantification study values for all needle gauges than for controls (P < 0.01).

In light of these findings, the researchers concluded that, even when a 32-G needle was used, intravitreal injection posed a risk of introducing contamination directly into the eye. However, they concluded that the 27-G needle posed the greatest risk of contamination of all the needle gauges they studied using these experimental models.

Related Coverage:

Smaller Inserter Performs Well for Injectable Uveitis Treatment

Difluprednate Shows Itself Effective for Intermediate Uveitis Treatment

Central Foveal Thickness Cut-off Value Identified for Corticosteroid Treatment in Intermediate Uveitis

Related Videos
Quan Dong Nguyen, MD: Phase 2 Neptune Trial Advances Brepocitnib for Uveitis | Image Credit: Stanford University
Charles C. Wykoff, MD, PhD: Phase 1b/2a Results on Restoret for DME, nAMD | Image Credit: Retina Consultants of Texas
Christine N. Kay, MD | Image Credit: Atsena Therapeutics
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
Christine N. Kay, MD: Interim Data on ATSN-201 Shows Promise for XLRS | Image Credit: Vitreo Retinal Associates
Arshad Khanani, MD: First Results from Fellow Eye Dosing of RGX-314 in nAMD | Image Credit: Sierra Eye Associates
Joel A. Pearlman, MD, PhD: Phase 2a Data on Oral RZ402 for DME | Image Credit: Retina Consultants Medical Group
Roger A. Goldberg, MD: Pooled Visual Function Data of NT-501 for MacTel | Image Credit: Bay Area Retina Associates
© 2024 MJH Life Sciences

All rights reserved.